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Presence of melatonin in
human tears
the  afternoon  (03:00  pm)  and  at  night  (12:00  pm).  Measure-
ments  were  performed  in  one  eye  of  each  patient,  selected
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Melatonin  is  a  neurohormone  mainly  considered  to  be
produced  by  the  pineal  gland.1 Melatonin  is  involved  in
processes  such  as  the  coordination  of  circadian  rhythms,
immunomodulation,  as  an  antidepressant,  antioxidant,  reg-
ulation  of  sex  organ  maturation,  in  embryonic  development
of  the  eye,  and  as  a  regulator  of  intraocular  pressure  among
other  actions.2
Melatonin  is  synthesised  and  secreted  in  more  tissues
than  just  the  pineal  gland.3 There  are  several  ocular  struc-
tures  that  also  produce  melatonin.  These  include  the  ciliary
body,  lens  and  the  retina.  Melatonin  acts  on  selective  mela-
tonin  receptors  located  in  the  cornea,  choroid  and  sclera.4
Melatonin  is  also  known  for  its  role  regulating  circadian
rhythms.2 The  presence  of  melatonin  in  rabbit  tears  has
been  described  in  a  2014  study  performed  with  New  Zealand
rabbits.  A  study  by  Crooke  et  al.  showed  the  presence
of  melatonin  in  the  tear  ﬁlm  but  the  production  of  the
melatonin  did  not  follow  a  circadian  pattern  as  expected.4
Although  this  neurohormone  has  been  identiﬁed  in  animal’s
ocular  surface,  little  is  known  about  the  effects  of  mela-
tonin  on  human  ocular  surface.  According  to  the  multitude
of  effects  of  this  compound  in  other  organisms  than  humans,
it  may  help  to  regulate  tear  secretion,  and  it  may  also  help
in  the  scavenging  of  reactive  oxygen  species  (ROS)  therefore
protecting  the  ocular  surface.6,7
The  presence  of  melatonin  and  its  diurnal  variation  in
human  tears  is  still  unclear.  To-date  the  presence  of  mela-
tonin  has  been  assessed  in  rabbit  tears  and  various  human
ocular  structures  and  the  aim  of  the  current  study  is  to  assess
the  presence  of  melatonin  in  the  human  tear  and  its  possible
variation  along  the  day--night  period.
In  this  study  11  subjects  (6  women/5  men)  aged
24.09  ±  1.87  (22--27  years)  were  recruited.  Subjects  with
any  ocular  pathology  were  excluded  from  the  study.  The
study  was  designed  and  performed  according  to  the  tenets
of  the  Declaration  of  Helsinki.  In  order  to  determine  the
concentration  of  melatonin  in  tears,  the  Schirmer’s  test
was  performed  for  2  min  as  described  Suphakasem  et  al.8
The  tear  volume  was  measured  in  human  tears  at  differ-
ent  time  points  of  the  day:  in  the  morning  (8:00  am),  in
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us  solution  for  further  individual  analysis  by  following  the
rocedure  described  by  Alkozi  and  Pintor.9 Statistical  data
nalysis  was  performed  by  the  IBM  SPSS  programme  (IBM
PSS  Statistics  for  Windows,  Version  23.0.  Armonk,  NY:  IBM
orp.),  using  the  non-parametric  test  Wilcoxon  signed  rank
est.  P  value  of  0.05  was  considered  statistically  signiﬁcant.
Melatonin  was  found  in  the  tears  of  the  subjects  and  the
oncentration  appears  to  change  throughout  the  day.  Fig.  1
hows  the  amount  of  melatonin  in  human  tears  at  differ-
nt  time  points  of  the  day.  Differences  between  melatonin
oncentrations  during  the  day  have  shown  a  circadian  pat-
ern.  In  the  morning  (8  h)  concentrations  were  (0.81[0.60,
.99]  M),  while  the  afternoon  (15  h)  concentrations  were
0.94  [0.69,  1.40]  M)  and  at  night  (24  h)  concentrations
ere  (1.67  [1.18,  3.25]  M).  The  differences  found  were
tatistically  signiﬁcant  (p  <  0.05;  p  =  0.008),  being  markedly
igher  at  night  (24  h)  than  in  the  morning  (8  h).  There  were
o  statistical  differences  (p  =  0.091)  between  the  afternoon
15  h)  and  the  morning  measurements.
In  this  study  it  has  been  described,  for  the  ﬁrst  time,
he  presence  of  melatonin  in  human  tears,  proving  also  that
he  production  of  this  neurohormone  follows  a  circadian
attern.  During  the  morning  and  evening  melatonin  levels
emain  stable,  but  it  doubles  its  concentration  overnight.
he  same  pattern  of  variation  has  been  found  in  other  tis-
ues  such  as  retina,  plasma  and  pineal  gland  according  to
awilska  and  co-workers.10
As  explained  previously,  melatonin  and  its  receptors
ave  been  found  in  various  structures  of  different  animals
yes,  signifying  that  it  is  a  very  important  component  in
he  eye  physiology.4 The  presence  of  melatonin  is  able  to
elp  corneal  wound  healing  by  activating  melatonin  MT2
eceptors,5 this  being  of  great  interest  for  potential  stud-
es  in  human  corneas.  Moreover,  in  experiments  performed
n  rabbits  tears,  it  was  observed  that  topical  administration
f  melatonin  in  combination  with  Ap4A  (a  natural  component
f  the  tear)  is  able  to  stimulate  tear  secretion.6
It  can  be  speculated  that  the  activation  of  a  TRPV4  chan-
el,  a  membrane  protein  present  in  the  ciliary  processes,
ncreases  the  secretion  of  extracellular  melatonin  to  the
queous  humour,  thus  regulating  intraocular  pressure.9 Nev-
rtheless,  since  the  results  show  a  circadian  pattern,  the
resence  of  melatonin  in  tears  might  also  be  regulated  by
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Figure  1  Melatonin  amount  in  human  tears  at  different
moments  of  the  day.  The  morning  (8  h)  concentrations  were
(0.81[0.60,  0.99]  M  (10--3  mol/L)),  afternoon  (15  h)  concentra-
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∗ Corresponding  author  at:  Faculty  of  Optic  and  Optometry,ions  were  (0.94  [0.69,  1.40]  M)  and  night  (24  h)  concentrations
ere  (1.67  [1.18,  3.25]  M)  (medians  and  quartiles).  Differences
iscussed  in  the  text.
he  same  mechanisms  as  the  ones  that  control  pineal  gland
hysiology.10
In  conclusion,  the  present  work  demonstrates  the  exist-
nce  of  melatonin  in  the  human  tear  ﬁlm.  Further  analysis
s  warranted  to  understand  the  role  of  melatonin  in  human
ears  and  ocular  surface.
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